Mangalurean woman Joyce Rego crowned ‘Mrs India Dubai'

Mangaluru, Jul 15: Amidst mounting coronavirus cases, the district administration has finalised 80 covid care centres (CCC) in Dakshina Kannada.

Sindhu B Rupesh, deputy commissioner of DK, said that as many as 80 premises that were functioning as quarantine centres have now been identified as CCCs in the district.

People in the district have been demanding that CCCs should be opened for asymptomatic cases in the district too. 

A majority of around 1,500 active cases in Dakshina Kannada are asymptomatic, and the CCCs will help those planning to go to private hospitals to reduce their treatment costs.

Additional deputy commissioner M J Roopa said that the 80 CCCs identified throughout the district will work as care centres for asymptomatic Covid-19 patients.

A medical team will attend to the centres, and supply of food and water will be taken care of by the government. In case of any health issues, the patient will be shifted to the Covid hospital, she said.

“All asymptotic Covid-19 patients, who are unable to opt for home isolation, are being kept in CCCs. A designated health team will monitor each CCC in the district. Meanwhile, the nearest public health centre (PHC) will have an ambulance on standby in case of an emergency,” she added.

Bengaluru, May 13: Former chief minister and senior Congress leader Siddaramaiah on Wednesday called the measures announced by Finance Minister Nirmala Sitharaman as 'disastrous' and said it is 'non-existent' in terms of benefits to poor migrants, labourers, contract employees and farmers.

"The first set of measures announced by @FinMinIndia @nsitharaman, after 8 PM speech by @narendramodi, is disastrous & non-existent in terms of benefits to poor migrants, labourers, contract employees, farmers, etc," Siddaramaiah said in a tweet.

The Congress leader said most of the intended benefits may not reach the end recipient.

This comes a day after Prime Minister Narendra Modi announced a Rs 20 lakh crore special economic package to revive the COVID-19 hit economy.

"The contribution by the government for the schemes announced are mostly notional and less of actuals and the devil lies in the detail," the Congress leader said in another tweet.

After Sitharaman announced support measures for MSMEs, Siddaramaiah said, "The credit infusion to MSMEs may help them clear dues to vendors but it is doubtful if they shall utilise the credit available to pay their labourers & to prevent job cuts. @FinMinIndia should have taken measures to pay part of the salaries to the employees in MSMEs."

Further questioning the Centre on 'ignoring the spending for boosting consumption', Siddaramaiah said, "The government is interested in capital infusion in the form of credits but totally ignorant of the actual spending that needs to be done to boost consumption. How can credit be considered as government spending?"

Siddaramaiah said the next set of measures should benefit the marginalised sections.

"Will be looking forward to next set of measures & I hope it will be something to benefit the marginalised sections. Direct benefits to the poorest sections will help them survive this pandemic. COVID-19 fight should not be another perception battle but a real one," he added in another tweet.

Sitharaman earlier announced Rs 3 lakh crore collateral-free automatic loans for businesses, including MSMEs.

Besides this, she also stated that to provide stressed MSMEs with equity support, the government will facilitate the provision of Rs 20,000 crore as subordinate debt.

Bengaluru, Mar 18: In the backdrop of the breakdown of the COVID-19 virus across the state, the ongoing Budget session of the Karnataka Assembly, which is scheduled to end of this month, is likely to be cut short by one week.

According to official sources, the state government, which had shut down all the congregating places including Malls, Theatres, Marriage Halls and banned all the public functions, is in favor of the cutting short the ongoing Assembly session, to give focus on keeping a tab on the COVID-19 disease.